Evidence map›Paper›PMID 34302064›Full record

ReviewCellular & molecular immunology2021

Dendritic cell migration in inflammation and immunity.

Juan Liu, Xiaomin Zhang, Yujie Cheng, Xuetao Cao

Open access · bronzeAbstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
327citing papers in PubMed, 1 pooled it
22.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

327 citing papers in PubMed, 1 synthesis or guideline pooled it, 485 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. IL-17D reprograms CD93Cellular & molecular immunology · 2026
    Article
  9. Article
  10. Sex Steroid Hormone Regulation of T-Cell Function and Antitumor Immunity.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Innate immunity: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

267 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Juan LiuNational Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China. juanliu@immunol.org.
Xiaomin ZhangNational Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China.
Yujie ChengNational Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China.
Xuetao CaoNational Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China. caoxt@immunol.org.
Second Military Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31870909National Natural Science Foundation of China (National Science Foundation of China) 32070903National Natural Science Foundation of China (National Science Foundation of China) 81788101
6 · The paper itself

Abstract

Dendritic cells (DCs) are the key link between innate immunity and adaptive immunity and play crucial roles in both the promotion of immune defense and the maintenance of immune tolerance. The trafficking of distinct DC subsets across lymphoid and nonlymphoid tissues is essential for DC-dependent activation and regulation of inflammation and immunity. DC chemotaxis and migration are triggered by interactions between chemokines and their receptors and regulated by multiple intracellular mechanisms, such as protein modification, epigenetic reprogramming, metabolic remodeling, and cytoskeletal rearrangement, in a tissue-specific manner. Dysregulation of DC migration may lead to abnormal positioning or activation of DCs, resulting in an imbalance of immune responses and even immune pathologies, including autoimmune responses, infectious diseases, allergic diseases and tumors. New strategies targeting the migration of distinct DC subsets are being explored for the treatment of inflammatory and infectious diseases and the development of novel DC-based vaccines. In this review, we will discuss the migratory routes and immunological consequences of distinct DC subsets, the molecular basis and regulatory mechanisms of migratory signaling in DCs, and the association of DC migration with the pathogenesis of autoimmune and infectious diseases.

Indexed as

Adaptive ImmunityAnimalsAutoimmune DiseasesAutoimmunityCell MovementCommunicable DiseasesDendritic CellsHumansInflammationReceptors, CCR7CCR7 protein, humanReceptors, CCR7autoimmune diseasescell migrationchemokine receptor CCR7dendritic cellsinflammation

Identifiers

PMID34302064
PMCPMC8298985
OpenAlexW3186513334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.